Results 71 to 80 of about 1,181 (123)

Real-world cost evaluation of conbercept vs. ranibizumab for retinal and choroidal vascular diseases from 2021 to 2024: evidence from societal and medical insurance perspectives. [PDF]

open access: yesBMC Public Health
Liu Y   +12 more
europepmc   +1 more source

Tetrahedral DNA nano-PROTACs enable enhanced ocular penetration and efficient nucleolin degradation for choroidal neovascularization therapy. [PDF]

open access: yesSignal Transduct Target Ther
Song J   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy